Nuclear receptor subfamily 3 group C member 1 pre-messenger RNA (NR3C1 pre-mRNA) (NR3C1 pre-mRNA)

Glucocorticoid receptor pre-mRNA is the primary transcript of the NR3C1 gene, which undergoes extensive alternative splicing to produce several protein isoforms, most notably the transcriptionally active GR-alpha and the dominant-negative GR-beta (Oakley & Cidlowski, 2013). The regulation of this pre-mRNA splicing is a critical determinant of cellular sensitivity to glucocorticoids, as an elevated GR-beta to GR-alpha ratio is frequently associated with glucocorticoid resistance in inflammatory and autoimmune diseases (Lewis-Tuffin & Cidlowski, 2006). As a therapeutic target, the pre-mRNA is being explored for modulation via antisense oligonucleotides (ASOs) designed to either degrade specific transcripts or alter splicing patterns to favor the active receptor isoform (Pujols et al., 2002). This approach offers a potential pathway to overcome steroid insensitivity by directly manipulating the molecular precursors of the receptor protein. Research in this area focuses on precision medicine applications where traditional steroid therapies fail due to isoform imbalances. However, challenges remain regarding the efficient delivery of RNA-targeting agents to specific tissues and the potential for off-target effects within the transcriptome.

Other names

Glucocorticoid receptor pre-mRNAGR pre-mRNAGCR pre-mRNANuclear receptor subfamily 3 group C member 1 primary transcript

Modulation of alternative splicing to alter the ratio of glucocorticoid receptor isoforms (e.g., GR-alpha vs. GR-beta) or degradation of the transcript via RNase H-mediated cleavage to reduce overall receptor expression in specific tissues.